Entity Details

Primary name ITM2B_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9Y287
EntryNameITM2B_HUMAN
FullNameIntegral membrane protein 2B
TaxID9606
Evidenceevidence at protein level
Length266
SequenceStatuscomplete
DateCreated2001-01-24
DateModified2021-06-02

Ontological Relatives

GenesITM2B

GO terms

Show/Hide Table
GOName
GO:0000139 Golgi membrane
GO:0001540 amyloid-beta binding
GO:0005524 ATP binding
GO:0005576 extracellular region
GO:0005615 extracellular space
GO:0005794 Golgi apparatus
GO:0005886 plasma membrane
GO:0007399 nervous system development
GO:0010008 endosome membrane
GO:0016020 membrane
GO:0030660 Golgi-associated vesicle membrane
GO:0031301 integral component of organelle membrane
GO:0042985 negative regulation of amyloid precursor protein biosynthetic process
GO:0043231 intracellular membrane-bounded organelle
GO:0070062 extracellular exosome
GO:1990000 amyloid fibril formation

Subcellular Location

Show/Hide Table
Subcellular Location
Cell membrane
Endosome membrane
Golgi apparatus membrane
Secreted

Domains

Show/Hide Table
DomainNameCategoryType
IPR007084 BRICHOS domainDomainDomain
IPR040145 Integral membrane protein 2FamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
616079 OMIMRetinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities (RDGCA)An autosomal dominant retinal dystrophy characterized by inner retinal dysfunction in association with ganglion cell abnormalities. Clinical features include mild photophobia, progressive loss of central vision, night blindness, and hyperreflectivity of nerve and ganglion cell layers. The disease is caused by variants affecting the gene represented in this entry.
176500 OMIMCerebral amyloid angiopathy, ITM2B-related 1 (CAA-ITM2B1)A disorder characterized by amyloid deposition in the walls of cerebral blood vessels and neurodegeneration in the central nervous system. Cerebral amyloid angiopathy, non-neuritic and perivascular plaques and neurofibrillary tangles are the predominant pathological lesions. Clinical features include progressive mental deterioration, spasticity and muscular rigidity. The disease is caused by variants affecting the gene represented in this entry. A single base substitution at the stop codon of ITM2B generates a 277-residue precursor that is cleaved at the normal furin processing site to generate the ABri amyloidogenic peptide (PubMed:10391242). ABri accumulates in the brain and produces amyloid fibrils responsible for neuronal dysfunction and dementia. ABri peptide variant forms fibrils in vitro (PubMed:10526337).
117300 OMIMCerebral amyloid angiopathy, ITM2B-related 2 (CAA-ITM2B2)A disorder characterized by amyloid deposition in the walls of the blood vessels of the cerebrum, choroid plexus, cerebellum, spinal cord and retina. Plaques and neurofibrillary tangles are observed in the hippocampus. Clinical features include progressive ataxia, dementia, cataracts and deafness. The disease is caused by variants affecting the gene represented in this entry. A decamer duplication in the 3' region of ITM2B results in the production of the ADan amyloidogenic peptide (PubMed:10781099). ADan is generated by cleavage of the mutated precursor at the normal furin processing site. ADan accumulates in the brain and produces amyloid fibrils responsible for neuronal dysfunction and dementia.